Summary: Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide and liraglutide, can cause dizziness as an uncommon side effect in up to 1 in 100 people
The dipeptide consists of just two amino acids (Ala-Glu or alanine-glutamic acid), making it one of the simplest bioregulator peptides yet reportedly effective for cartilage regeneration , joint mobility improvement, and age-related joint degeneration prevention
These behavioral improvements occur naturally as the medication reduces both physiologic hunger and the reward-driven impulses that encourage overeating
To reduce side effects, clinicians typically begin at the lowest dose and increase slowly
Novartis: Bimagrumab/BYM338 Bimagrumab is an antibody against activin type II receptor (ActRII) meaning that it acts as an ActRII antagonist (It prevents ActRII from functioning)
ConceioGMartinsDM MirandaILeite-MoreiraAFVitorinoRFalco-PiresI